Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HYR04 capsules for knee osteoarthritis with the traditional Chinese medicine cold-dampness obstruction pattern
CTR20263364Phase 2Active
- Sponsor
- Tiandi Hengyi Pharmaceutical
- Start
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing HYR04 capsule with Matching placebo (2 arms). Primary endpoint: Change from baseline in target-knee pain visual analog scale score. Started Aug 2026; status: active.
02
Drugs
HYR04
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20263364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263364.